Cargando…
Comprehensive mutagenesis identifies the peptide repertoire of a p53 T-cell receptor mimic antibody that displays no toxicity in mice transgenic for human HLA-A*0201
T-cell receptor mimic (TCRm) antibodies have expanded the repertoire of antigens targetable by monoclonal antibodies, to include peptides derived from intracellular proteins that are presented by major histocompatibility complex class I (MHC-I) molecules on the cell surface. We have previously used...
Autores principales: | Trenevska, Iva, Anderson, Amanda P., Bentley, Carol, Hassanali, Tasneem, Wiblin, Sarah, Maguire, Shaun, Pezzella, Francesco, Banham, Alison H., Li, Demin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034716/ https://www.ncbi.nlm.nih.gov/pubmed/33836029 http://dx.doi.org/10.1371/journal.pone.0249967 |
Ejemplares similares
-
Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies
por: Li, Demin, et al.
Publicado: (2017) -
Therapeutic Antibodies against Intracellular Tumor Antigens
por: Trenevska, Iva, et al.
Publicado: (2017) -
CD8(+) T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein
por: Zhao, Kai, et al.
Publicado: (2010) -
Recognition of Human Proinsulin Leader Sequence by Class I–Restricted T-Cells in HLA-A*0201 Transgenic Mice and in Human Type 1 Diabetes
por: Toma, Andréa, et al.
Publicado: (2009) -
Identification of a novel PD-L1 positive solid tumor transplantable in
HLA-A*0201/DRB1*0101 transgenic mice
por: Rangan, Laurie, et al.
Publicado: (2017)